OREANDA-NEWS. Merck, a leading science and technology company, today announced the launch of its first-in-class Lynx(r) CDR connectors to improve fluid management in the biopharma industry. The Lynx(r) CDR connectors debut at the International Pharmaceutical Expo (INTERPHEX) event in New York, New York, April 26-28.

"Lynx(r) CDR connectors will change the way pharmaceutical fluids are managed, lowering drug manufacturing costs," said Udit Batra, CEO, Life Science at Merck. "The Lynx(r) CDR connectors set a new standard for sterile fluid connections, dramatically improving ease of use and reliability."

Making simple, reliable, sterile-to-sterile fluid connections is critical to successful biomanufacturing. Previous disposable connector technology allowed users to make only a single sterile connection per device, requiring the use of multiple devices per unit operation. Previous technology also required a dry, non-pressurized flow path during connection and disconnection. These limitations are resource- and cost-intensive when industry standards demand increased productivity and improved efficiency at all stages of the drug manufacturing process. With the Lynx(r) CDR connectors, users can perform faster, more economic fluid management when the flow path is wet and pressurized.